Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Global Times: China's silver economy unleashes diversified opportunities, fueling growth of multiple sectors 2025-09-22 21:26
Global Times: China's silver economy: innovation, dignity, and shared opportunities 2025-09-22 21:20
Galux Demonstrates De Novo Antibody Design With Structural and Functional Validation Across Eight Targets 2025-09-22 21:00
Lunit and Agilent Technologies Announce Collaboration to Enhance Development of Companion Diagnostic Solutions Powered with AI for Precision Medicine 2025-09-22 21:00
LakeShore Biopharma Announces Transition to OTC Market Following Nasdaq Delisting 2025-09-22 20:00
Akeso Announces First Patient Dosed in Registrational Phase II Study of TIGIT/TGF-β Bifunctional Antibody Fusion Protein AK130 Combined with Ivonescimab for Advanced Pancreatic Cancer 2025-09-22 14:51
Ascletis Announces ASC47 in Combination with Semaglutide Demonstrated Up to 56.2% Greater Relative Reduction in Body Weight in Participants with Obesity Compared to Semaglutide Monotherapy 2025-09-22 08:10
Innovent Announces Mazdutide Received Approval from China's NMPA for Glycemic Control in Adults with Type 2 Diabetes 2025-09-19 18:01
DarwinCell Showcases novel MSC-based drug ALT001 at the 150th American Neurological Association Annual Meeting 2025-09-19 17:28
International Doctors Visit Smartee HQ and Share Insights on Next-Generation Orthodontics 2025-09-19 14:35
2025 IMS | IASO Bio Highlights Three-Year Follow-Up Data of CAR-T Cell Therapy Fucaso for Multiple Myeloma Treatment 2025-09-19 09:39
QL Biopharm reports Phase 2 results of a monthly dose study evaluating zovaglutide, a novel, extended half-life GLP-1 receptor agonist at EASD 2025 2025-09-18 21:00
Innovent's Partner Ollin Announces Clinical Updates on IBI324 (OLN324, VEGF/ANG-2) 2025-09-18 12:00
Neuronata-R® Phase 3 Results Confirm Subgroup Benefit at PACTALS 2025, Strengthening Biomarker-Driven Pathway 2025-09-18 10:28
CARsgen Presents Updated Long-term Follow-up Results for Zevor-cel at IMS 2025 2025-09-18 08:15
Ascletis Presented Phase III Study Results of First-in-Class FASN Inhibitor Denifanstat (ASC40) for Acne Treatment in the Late Breaking News Sessions of the European Academy of Dermatology and Venereology (EADV) Congress 2025 2025-09-18 07:30
MagicRNA's First-in-Human Clinical Data Demonstrating Feasibility of In Vivo CAR T Therapy in Systemic Lupus Erythematosus Published in The New England Journal of Medicine. 2025-09-18 05:09
Dornier MedTech America launches Hoover™ and AXIS® II SLIM, raising the bar in kidney stone treatment 2025-09-17 22:00
Mabwell Bioscience and Aditum Bio Announce Formation of Kalexo Bio to Advance Innovative siRNA Therapy for Cardiovascular Disorders 2025-09-17 20:00
Alteogen Receives European Commission Approval for Aflibercept Biosimilar, EYLUXVI® (ALT-L9) 2025-09-17 15:40
1 14 15 16 17 18 871